These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 29213947)
1. Reversible dementia due to neurocysticercosis: Improvement of the racemose type with antihistamines. Machado-Porto GCL; Lucato LT; Porto FHG; de Souza EC; Nitrini R Dement Neuropsychol; 2015; 9(1):85-90. PubMed ID: 29213947 [TBL] [Abstract][Full Text] [Related]
2. Reversible dementia as a presenting manifestation of racemose neurocysticercosis. Sharma S; Modi M; Lal V; Prabhakar S; Bhardwaj A; Sehgal R Ann Indian Acad Neurol; 2013 Jan; 16(1):88-90. PubMed ID: 23661971 [TBL] [Abstract][Full Text] [Related]
4. Extraparenchymal (Racemose) Neurocysticercosis and Its Multitude Manifestations: A Comprehensive Review. Mahale RR; Mehta A; Rangasetty S J Clin Neurol; 2015 Jul; 11(3):203-11. PubMed ID: 26022457 [TBL] [Abstract][Full Text] [Related]
5. [Giant racemose subarachnoid and intraventricular neurocysticercosis: A case report]. Sanchez-Larsen A; Monteagudo M; Lozano-Setien E; Garcia-Garcia J Rev Argent Microbiol; 2015; 47(3):201-5. PubMed ID: 26321177 [TBL] [Abstract][Full Text] [Related]
6. Treatment of racemose neurocysticercosis. McClugage SG; Lee RA; Camins BC; Mercado-Acosta JJ; Rodriguez M; Riley KO Surg Neurol Int; 2017; 8():168. PubMed ID: 28840072 [TBL] [Abstract][Full Text] [Related]
7. Bruns' syndrome and racemose neurocysticercosis: a case report. Diehl Rodriquez R; Crestani DN; Dworzecki Soares JO; Franceshini PR; Petersen Alves R; Zimerman R; Ferreira N; Menke Barea L Rev Soc Bras Med Trop; 2012; 45(2):269-71. PubMed ID: 22535007 [TBL] [Abstract][Full Text] [Related]
8. Proliferative cells in racemose neurocysticercosis have an active MAPK signalling pathway and respond to metformin treatment. Orrego MA; Verastegui MR; Vasquez CM; Garcia HH; Nash TE; Int J Parasitol; 2022 May; 52(6):377-383. PubMed ID: 35182540 [TBL] [Abstract][Full Text] [Related]
9. Taenia crassiceps injection into the subarachnoid space of rats simulates radiological and morphological features of racemose neurocysticercosis. Hamamoto Filho PT; Fabro AT; Rodrigues MV; Bazan R; Vulcano LC; Biondi GF; Zanini MA Childs Nerv Syst; 2017 Jan; 33(1):119-123. PubMed ID: 27613638 [TBL] [Abstract][Full Text] [Related]
10. Identification and culture of proliferative cells in abnormal Taenia solium larvae: Role in the development of racemose neurocysticercosis. Orrego MA; Verastegui MR; Vasquez CM; Koziol U; Laclette JP; Garcia HH; Nash TE; PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009303. PubMed ID: 33750965 [TBL] [Abstract][Full Text] [Related]
11. Subarachnoid racemose neurocysticercosis with cerebellar involvement: an old friend in an infrequent location? Parra-Cárdenas DM; Vargas-Cuervo MT; Montejo-Coy JA; Calderon-Vargas CM; Severiche-Bueno DF Rev Inst Med Trop Sao Paulo; 2021; 63():e43. PubMed ID: 34161549 [TBL] [Abstract][Full Text] [Related]
12. A rare case of racemose neurocysticercosis and its complications. Case report. Pamplona J; Braz A; Conceição C; Rios C; Reis J Neuroradiol J; 2015 Aug; 28(4):418-20. PubMed ID: 26416817 [TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of cysticercosis and neurocysticercosis]. Bouteille B Med Sante Trop; 2014; 24(4):367-74. PubMed ID: 25296005 [TBL] [Abstract][Full Text] [Related]